Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE

AMER THORACIC SOC

1. Sanofi Genzyme
2. National Institute for Health Research (NIHR Leicester Biomedical Research Centre)
3. National Institute for Health Research (NIHR Oxford Biomedical Research Centre)
4. Medical Research Council (MRC Refractory Asthma Stratification Programme)
5. Wellcome Trust [211050/Z/18/Z]
6. Beit Fellowship [211050/Z/18/A]
7. Wellcome Trust [211050/Z/18/A] Funding Source: Wellcome Trust